Thrombolytic treatment in obliterative arterial disease. Can thrombolytic agents compete with surgery?

Haemostasis. 1986:16 Suppl 3:83-5. doi: 10.1159/000215371.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arterial Occlusive Diseases / drug therapy*
  • Catheterization / adverse effects
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Infusions, Intra-Arterial
  • Middle Aged

Substances

  • Fibrinolytic Agents